Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Anixa Biosciences Inc

ANIX
Current price
2.48 USD +0.07 USD (+2.90%)
Last closed 2.42 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 77 038 016 USD
Yield for 12 month -21.52 %
1Y
3Y
5Y
10Y
15Y
ANIX
21.11.2021 - 28.11.2021

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California. Address: 3150 Almaden Expressway, San Jose, CA, United States, 95118

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12 USD

P/E ratio

Dividend Yield

Current Year

+210 000 USD

Last Year

+2 469 000 000 USD

Current Quarter

Last Quarter

+156 000 USD

Current Year

+49 000 USD

Last Year

+2 468 958 000 USD

Current Quarter

-13 000 USD

Last Quarter

+144 000 USD

Key Figures ANIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -13 097 416 USD
Operating Margin TTM -5744.76 %
PE Ratio
Return On Assets TTM -28.09 %
PEG Ratio
Return On Equity TTM -43.02 %
Wall Street Target Price 12 USD
Revenue TTM 210 000 USD
Book Value 0.78 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 127 498 USD
Earnings per share -0.34 USD
Diluted Eps TTM -0.34 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ANIX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ANIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 26.06.2015
Dividend Date

Stock Valuation ANIX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 368.9827
Price Sales TTM 481.5351
Enterprise Value EBITDA -6.4486
Price Book MRQ 4.1098

Financials ANIX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ANIX

For 52 weeks

2.4 USD 5.13 USD
50 Day MA 3.11 USD
Shares Short Prior Month 632 103
200 Day MA 3.51 USD
Short Ratio 6.01
Shares Short 554 326
Short Percent 3.31 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds


S

SX7EEX

14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics